Madrigal Pharmaceuticals net total equity issued/repurchased for the twelve months ending March 31, 2025 was $2.167B, a 80.47% increase year-over-year.
Madrigal Pharmaceuticals annual net total equity issued/repurchased for 2024 was $0.735B, a 38.57% increase from 2023.
Madrigal Pharmaceuticals annual net total equity issued/repurchased for 2023 was $0.53B, a 100.68% increase from 2022.
Madrigal Pharmaceuticals annual net total equity issued/repurchased for 2022 was $0.264B, a 55.3% increase from 2021.
Madrigal Pharmaceuticals Net Total Equity Issued/Repurchased 2010-2025 | MDGL